Evidence map›Paper›PMID 37656559›Full record

ArticleOptics letters2023

Pulse-sampling fluorescence lifetime imaging: evaluation of photon economy.

Xiangnan Zhou, Julien Bec, Katjana Ehrlich, Alba Alfonso Garcia, Laura Marcu

Abstract read
In one paragraph

Article in Optics letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiangnan Zhou
Julien Bec
Katjana Ehrlich
Alba Alfonso Garcia
Laura Marcu

Funding

TRD3: Percutaneous and Interstitial ImagingP41EB015903 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Jacqueline Namati · 2012 to 2026
$22.4M
TRD3: Data Analytics and Intelligent Systems (AI-ML-DL-Visualization)P41EB032840 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Griffith R. Harsh · 2022 to 2026
$6.7M
Fluorescence Lifetime Imaging/Spectroscopy System For Robotic Cancer Surgery GuidanceR01CA187427 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, MARCU, LAURA · 2014 to 2025
$4.6M
Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patientsR01HL157712 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BOUMA, BRETT E, MARCU, LAURA · 2021 to 2025
$3.4M
Label-free fluorescence lifetime imaging for intraoperative real-time guidance of neurological proceduresR01CA250512 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Orin Bloch, Laura Marcu · 2021 to 2026
$3.0M
NCI NIH HHS R01 CA187427NCI NIH HHS R01 CA250512NHLBI NIH HHS R01 HL157712NIBIB NIH HHS P41 EB015903NIBIB NIH HHS P41 EB032840
6 · The paper itself

Abstract

This Letter presents an experimental study comparing the photon rate and photon economy of pulse sampling fluorescence lifetime imaging (PS-FLIm) with the conventional time-correlated single photon counting (TCSPC) technique. We found that PS-FLIm has a significantly higher photon detection rate (200 MHz) compared with TCSPC (2-8 MHz) but lower photon economy (4-5 versus 1-1.3). The main factor contributing to the lower photon economy in PS-FLIm is laser pulse variability. These results demonstrate that PS-FLIm offers 25× faster imaging speed than TCSPC while maintaining room light rejection in clinical settings. This makes PS-FLIm a robust technique for clinical applications.

Identifiers

PMID37656559
PMCPMC10883700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.